We are live on ! Find out more
NVS icon

Novartis
NVS

878 hedge funds and large institutions have $19.5B invested in Novartis in 2016 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 341 increasing their positions, 311 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more funds holding in top 10

Funds holding in top 10: 21 → 37 (+16)

23% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 56

13% more capital invested

Capital invested by funds: $17.3B → $19.5B (+$2.17B)

10% more repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 311

4% more call options, than puts

Call options by funds: $62.8M | Put options by funds: $60.5M

0% more funds holding

Funds holding: 875 → 878 (+3)

0.1% more ownership

Funds ownership: 9.94% → 10.04% (+0.1%)

Holders
878
Holders Change
+3
Holders Change %
+0.34%
% of All Funds
23.43%
Holding in Top 10
37
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+76.19%
% of All Funds
0.99%
New
69
Increased
341
Reduced
311
Closed
56
Calls
$62.8M
Puts
$60.5M
Net Calls
+$2.27M
Net Calls Change
+$2.74M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$120M
2
Parnassus Investments
Parnassus Investments
California
+$102M
3
T
Thomaspartners
Massachusetts
+$87.6M
4
Aristotle Capital Management
Aristotle Capital Management
California
+$51.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.9M

Top Sellers

1
IC
Institutional Capital
Illinois
-$276M
2
Renaissance Technologies
Renaissance Technologies
New York
-$77.4M
3
Dodge & Cox
Dodge & Cox
California
-$53.1M
4
State Street
State Street
Massachusetts
-$47.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
26
Capital World Investors
California
$151M – – –
Boston Partners
27
Boston Partners
Massachusetts
$149M -$13.5M -195,458 -9%
Morgan Stanley
28
Morgan Stanley
New York
$147M -$1.65M -23,852 -1%
Fayez Sarofim & Co
29
Fayez Sarofim & Co
Texas
$133M +$6M +86,822 +5%
Capital International Investors
30
Capital International Investors
California
$121M – – –
Ameriprise
31
Ameriprise
Minnesota
$120M +$2.18M +31,490 +2%
FWIA
32
Fort Washington Investment Advisors
Ohio
$118M +$3.25M +47,088 +3%
USSCPF
33
United States Steel & Carnegie Pension Fund
New York
$114M – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$112M -$9.94M -143,846 -9%
SCCM
35
Schafer Cullen Capital Management
New York
$111M +$1.27M +18,399 +1%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$100M +$50.2K +726 +0.1%
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$100M +$473K +6,841 +0.5%
Fidelity Investments
38
Fidelity Investments
Massachusetts
$99.7M +$36.9M +534,206 +66%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$95.4M +$6.57M +95,095 +8%
RFS
40
Rockefeller Financial Services
New York
$94.6M -$765K -11,074 -0.9%
PPA
41
Parametric Portfolio Associates
Washington
$93.7M +$3.38M +48,894 +4%
SCM
42
Sterling Capital Management
North Carolina
$88.5M -$180K -2,602 -0.2%
SI
43
Scharf Investments
California
$88.5M +$2.58M +37,279 +3%
SC
44
Saturna Capital
Washington
$87.4M -$34.7K -502 -0%
AG
45
Aperio Group
California
$80.3M +$16.2M +233,768 +27%
Natixis Advisors
46
Natixis Advisors
Massachusetts
$79.5M +$14.4M +208,228 +24%
Goldman Sachs
47
Goldman Sachs
New York
$71.9M -$3.22M -46,548 -5%
EAM
48
Edge Asset Management
Washington
$67.5M +$2.7M +39,028 +4%
MHI
49
Miller Howard Investments
New York
$67.3M -$2.61M -37,767 -4%
JWBC
50
John W. Bristol & Co
New York
$64.9M -$3.47M -50,181 -5%
1
2
3 4 5

NVS Hedge Fund Activity: Q2 2016 in Review

878 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q2 2016, worth a combined $19.5B — up 13% from $17.3B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new NVS positions and 56 closed out — a net gain of 13 holders — while 341 added to existing stakes and 311 trimmed.

The largest buyer was Macquarie Group, adding an estimated $120M. The largest seller was Institutional Capital, exiting entirely with an estimated $276M sold.

  • 878 institutional investors held Novartis (NVS) as of Q2 2016, up from 875 in Q1 2016.
  • Funds reported $19.5B of Novartis stock for Q2 2016, up 13% quarter-over-quarter.
  • 69 funds opened new Novartis positions in Q2 2016 and 56 closed out, a net change of +13 holders.
  • The largest Novartis buyer in Q2 2016 was Macquarie Group, an estimated $120M added.
  • The largest Novartis seller in Q2 2016 was Institutional Capital, an estimated $276M sold.

Based on aggregated 13F filings for Q2 2016.